論文

査読有り 国際誌
2020年2月12日

Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study.

Biochemical and biophysical research communications
  • Saki Yoshinaga
  • ,
  • Tomoyuki Yamanaka
  • ,
  • Haruko Miyazaki
  • ,
  • Ayami Okuzumi
  • ,
  • Akiko Hiyama
  • ,
  • Shigeo Murayama
  • ,
  • Nobuyuki Nukina

522
3
開始ページ
655
終了ページ
661
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.bbrc.2019.11.142

Many pathological proteins related to neurodegenerative diseases are misfolded, aggregating to form amyloid fibrils during pathogenesis. One of the pathological proteins, alpha-synuclein (α-syn), accumulates in the brains of Parkinson disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), which are designated as synucleinopathies. Recently, structural properties of abnormal accumulated proteins are suggested to determine the disease phenotype. However, the biochemical and structural characteristics of those accumulated proteins are still poorly understood. We previously reported the sequence and seed-structure-dependent polymorphic fibrils of α-syn and the polymorphism was identified by proteinase K-resistant cores determined by mass spectrometry (MS) analysis. In this study, we applied this method to analyze α-syn aggregates of MSA and DLB. To perform MS analysis on proteinase K-resistant cores, we first performed amplification of α-syn aggregates by seeding reaction and protein misfolding cyclic amplification (PMCA) to obtain a sufficient amount of aggregates. Using SDS insoluble fraction of the disease brain, we successfully amplified enough α-syn aggregates for MS analysis. We differentiated between mouse and human α-syn aggregates by MS analysis on proteinase K-resistant cores of the aggregates before and after amplification. The results suggest that structural properties of amplified α-syn fibrils are preserved after PMCA and these methods can be applicable in the study of pathological proteins of the neurodegenerative disorders.

リンク情報
DOI
https://doi.org/10.1016/j.bbrc.2019.11.142
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31785806
ID情報
  • DOI : 10.1016/j.bbrc.2019.11.142
  • PubMed ID : 31785806

エクスポート
BibTeX RIS